A carregar...

Hearing evaluation of head and neck cancer patients (HNCP): Comparison of CTCAE, Brock and Chang adverse event (AE) criteria in patients receiving cisplatin (CDDP)

PURPOSE: To compare CTCAE, Brock and Chang hearing loss (HL) grading in HNCP receiving CDDP. Endpoints were baseline distribution of HL, inter-observer consistency, and sensitivity to HL following CDDP treatment. METHODS: 460 single ear audiograms in 110 HNCP were graded. HL at baseline, inter-obser...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Head Neck
Main Authors: Colevas, A. D., Lira, R. R., Colevas, E. A., Lavori, P. W., Chan, C., Shultz, D. B., Chang, K. W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4780572/
https://ncbi.nlm.nih.gov/pubmed/24737682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hed.23714
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!